RTW Biotech Opportunities (LSE:RTW) Shares Outstanding (EOP): 326.4 Mil (As of Dec. 2025)


LSE:RTW RTW Biotech Opportunities Ltd LSE:RTW
36 GF Score
Price $2.42
! 2 Warning Signs
View Full Analysis

What is RTW Biotech Opportunities Shares Outstanding (EOP)?

RTW Biotech Opportunities LSE:RTW +0.83% 36 Shares Outstanding (EOP) is 326.4 Mil as of Dec. 2025. GuruFocus rates LSE:RTW with a GF Score™ of 36/100. The stock has 2 warning signs investors should review.

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. RTW Biotech Opportunities's shares outstanding for the quarter that ended in Dec. 2025 was 326.4 Mil.

RTW Biotech Opportunities's quarterly shares outstanding declined from Jun. 2025 (330.1 Mil) to Dec. 2025 (326.4 Mil). It means RTW Biotech Opportunities bought back shares from Jun. 2025 to Dec. 2025 .

RTW Biotech Opportunities's annual shares outstanding declined from Dec. 2024 (335.7 Mil) to Dec. 2025 (326.4 Mil). It means RTW Biotech Opportunities bought back shares from Dec. 2024 to Dec. 2025 .


RTW Biotech Opportunities  (LSE:RTW) Shares Outstanding (EOP) Explanation

A company may buy back shares or issue shares in any fiscal period. If a company buys back shares, we should observe that the total number of shares decline. If the company issues new shares, the number of shares outstanding increases.

Usually the presence of treasury shares and a history of buyback are good indicators that company has competitive advantage. But studies have shown that companies usually buy back at wrong time. Buying back shares below its intrinsic value increases value for remaining shareholders. Buying back overvalued shares destroys value for existing shareholders.


Be Aware

Warren Buffett looks for consistency and upward long term trend. Because of share repurchase it is possible for net earnings trend to differ from EPS trend. He preferred net income over EPS. The companies with durable competitive advantage companies report higher % net earnings to total revenues.

Important: If a company is showing net earnings history greater than 20% on total revenues, it is probably benefiting from a long term competitive advantage.

If net earnings is less than 10%, likely to be in a highly competitive business.


RTW Biotech Opportunities Shares Outstanding (EOP) Related Terms


RTW Biotech Opportunities Shares Outstanding (EOP) Historical Data

* Premium members only.

The historical data trend for RTW Biotech Opportunities's Shares Outstanding (EOP) can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

RTW Biotech Opportunities Shares Outstanding (EOP) Chart

RTW Biotech Opportunities Annual Data
Trend Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
Shares Outstanding (EOP)
Get a 7-Day Free Trial 212.39 212.39 210.64 335.71 326.37

RTW Biotech Opportunities Semi-Annual Data
Dec18 Jun19 Dec19 Jun20 Dec20 Jun21 Dec21 Jun22 Dec22 Jun23 Dec23 Jun24 Dec24 Jun25 Dec25
Shares Outstanding (EOP) Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 210.64 335.71 335.71 330.06 326.37

LSE:RTW vs BLK, BX, KKR: Shares Outstanding (EOP) Comparison

For the Asset Management subindustry, RTW Biotech Opportunities's Shares Outstanding (EOP), along with its competitors' market caps and Shares Outstanding (EOP) data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


RTW Biotech Opportunities Shares Outstanding (EOP) vs Asset Management Industry

For the Asset Management industry and Financial Services sector, RTW Biotech Opportunities's Shares Outstanding (EOP) distribution charts can be found below:

* The bar in red indicates where RTW Biotech Opportunities's Shares Outstanding (EOP) falls into.


LSE:RTW
36GF Score
RTW Biotech Opportunities Ltd LSE:RTW
Shares Outstanding (EOP) is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

RTW Biotech Opportunities Shares Outstanding (EOP) Calculation

Shares outstanding are shares that have been authorized, issued, and purchased by investors and are held by them. They have voting rights and represent ownership in the corporation by the person that holds the shares. They should be distinguished from treasury shares, which are shares held by the corporation itself, having no exercisable rights.

Shares outstanding can be calculated as either basic or fully diluted. The fully diluted shares outstanding count includes diluting securities, such as options, warrants or convertibles.

Please note: GuruFocus named Shares Outstanding (EOP) is the shares for that end of period. It is usually used to calculate balance sheet related items, such as Book Value per Share, etc. While Shares Outstanding (Diluted Average) and Shares Outstanding (Basic Average) are the weighted average shares over a period of time (a year, a quarter, or so). They are usually used to calculate income statement or cashflow statement related items, such as Earnings per Share (Diluted), etc.

What does a Shares Outstanding (EOP) of 326.4 Mil mean?
RTW Biotech Opportunities (LSE:RTW) has a Shares Outstanding (EOP) of 326.4 Mil as of Dec. 2025. The total shares a company has outstanding, at period-end. View historical data on RTW Biotech Opportunities and its competitors.
Is RTW Biotech Opportunities' Shares Outstanding (EOP) too high?
RTW Biotech Opportunities' current Shares Outstanding (EOP) is 326.4 Mil. Overall, RTW Biotech Opportunities has a GF Score™ of 36/100, reflecting its overall financial health beyond just this single metric.
How does RTW Biotech Opportunities' Shares Outstanding (EOP) compare to BLK and BX?
RTW Biotech Opportunities' Shares Outstanding (EOP) of 326.4 Mil can be compared against companies in the Asset Management industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Shares Outstanding (EOP) for an Asset Management company?
A good Shares Outstanding (EOP) depends on the Asset Management industry context. However, Shares Outstanding (EOP) should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Shares Outstanding (EOP) mean?
A high Shares Outstanding (EOP) can signal that a stock is expensive relative to its fundamentals. The total shares a company has outstanding, at period-end. View historical data on RTW Biotech Opportunities and its competitors. RTW Biotech Opportunities's current Shares Outstanding (EOP) is 326.4 Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is RTW Biotech Opportunities stock overvalued right now?
RTW Biotech Opportunities (LSE:RTW) has a current Shares Outstanding (EOP) of 326.4 Mil. The current Shares Outstanding (EOP) is 326.4 Mil. RTW Biotech Opportunities' overall GF Score™ is 36/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Shares Outstanding (EOP) calculated?
Shares Outstanding (EOP) is calculated from a company's financial statements. For RTW Biotech Opportunities (LSE:RTW), the current Shares Outstanding (EOP) is 326.4 Mil as of Dec. 2025. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

RTW Biotech Opportunities Business Description

Address St Julian’s Avenue, 1st Floor, Royal Chambers, St Peter Port, GGY, GY1 3JX
RTW Biotech Opportunities Ltd is a life sciences and investment fund focused on identifying transformative assets with high growth potential across the biopharma and medtech sectors. It is powering medical breakthroughs that have the potential to transform the wellbeing of people around the world. Its portfolio includes Neurology, Oncology, Inflammation, Cardiovascular, Metabolic, Pulmonary, Ophthalmology, Rare Disease, and Other. Geographically it operates in USA & Canada, the Rest of World, and UK & EU, with the majority of the revenue deriving from USA & Canada.
36GF Score

Get the complete analysis for LSE:RTW

Shares Outstanding (EOP) is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$2.42
Price